SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-306562
Filing Date
2017-10-10
Accepted
2017-10-10 09:02:55
Documents
66
Period of Report
2017-08-31

Document Format Files

Seq Description Document Type Size
1 10-Q d654223d10q.htm 10-Q 267765
2 EX-31.1 d654223dex311.htm EX-31.1 9351
3 EX-31.2 d654223dex312.htm EX-31.2 9343
4 EX-32.1 d654223dex321.htm EX-32.1 3725
5 EX-32.2 d654223dex322.htm EX-32.2 3701
  Complete submission text file 0001193125-17-306562.txt   3468045

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cydy-20170831.xml EX-101.INS 465103
7 XBRL TAXONOMY EXTENSION SCHEMA cydy-20170831.xsd EX-101.SCH 55284
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cydy-20170831_cal.xml EX-101.CAL 48734
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cydy-20170831_def.xml EX-101.DEF 321444
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cydy-20170831_lab.xml EX-101.LAB 403158
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cydy-20170831_pre.xml EX-101.PRE 371831
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-49908 | Film No.: 171128892
SIC: 2834 Pharmaceutical Preparations